Press & Coverage · 2025–2026

News & Media Coverage.

Latest press, launches, and coverage on ZoyeMed 3.0 - from WHX Dubai 2026 to clinical deployments in Mexico and Colombia.

5 Articles Published
3 Countries Covered
WHX Dubai 2026 Feature Launch
5 articles

All Coverage

Sorted by date · newest first

What They're Saying

Press & Independent Coverage.

WHX Dubai 2026

"A system that could fundamentally reshape how healthcare is delivered in the world's most challenging environments - merging the clinical depth of a hospital with the footprint of a terminal."

February 2026 · Feature Coverage

Mediworld Middle East

"Dr. Azim's philosophy is clear: technology must earn its place at the bedside by acquiring ground truth first - not by reasoning from patient narratives alone."

December 2025 · Exclusive Interview

BusinessWire

"ZoyeMed 3.0's edge-native architecture means clinical AI inference happens on-device - eliminating cloud dependency and enabling data sovereignty by design, not by policy."

February 2026 · Press Release

Grupo Salinas · Más Salud Launch

"An innovative healthcare model designed to transform how Mexicans access health services - clinical-grade diagnostics at the point of daily commerce."

December 2025 · Deployment Coverage

Stay Informed

Follow the deployment story.

For enterprise enquiries, media briefings, and press materials - contact our team directly. Technical white papers and the PMCF report are available to qualified reviewers.

Zoyel® and ZoyeMed® are registered trademarks of Zoya Technologies LLC (India, China, UAE). The ZoyeMed terminal is general-purpose clinical IT infrastructure, device-agnostic by design, deployed with separately certified medical device and IVD modules supplied under each manufacturer's own conformity marking. Terminal hardware: CE Electrical and NYCE Mexico certified; integrated-configuration CE-MDR assessment, COFEPRIS (Mexico) and INVIMA (Colombia) in process. Zoyel.Health is licensed as Class B Software as a Medical Device under India's CDSCO framework. Zoyel.Health provides clinical decision support; final diagnostic and prescribing decisions remain with a licensed clinician. Regulatory status varies by jurisdiction. Zoyel SSM is delivered jointly by Zoya Technologies LLC and Zoya Technologies Malaysia Sdn Bhd. Longitudinal multimodal model architecture: PCT application filed Q1 2026. Nothing on this site is an offer; commercial terms are set only in a signed agreement.